3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
19
Polycystic Ovary Syndrome
10
Prostatic Neoplasms
7
Breast Neoplasms
6
Neoplasms
5
Colorectal Neoplasms
4
Insulin Resistance
3
Lung Neoplasms
2
Fatigue
2
Esophageal Neoplasms
2
Cardiotoxicity
2
Stomach Neoplasms
1
Rectal Neoplasms
1
Primary Dysautonomias
1
Pediatric Brain Tumor
1
Ovarian Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Lupus Erythematosus, Systemic
1
Inflammation
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Disease
1
Diabetes Mellitus, Type 1
1
Chemotherapy-Related Cognitive Impairment
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Cachexia
1
Interventions
Endoscopy, Digestive System
3
Endoscopy
3
Radiotherapy
2
Biopsy
2
chlorhexidine gluconate
1
Specimen Handling
1
Risk Assessment
1
Radiation
1
Nivolumab
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Immune Checkpoint Inhibitors
1
High-Throughput Screening Assays
1
High-Intensity Interval Training
1
Hematologic Tests
1
Gene Expression Profiling
1
Fluorodeoxyglucose F18
1
Fecal Microbiota Transplantation
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
Endoscopic Mucosal Resection
1
Drug Therapy
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Adenocarcinoma Of Esophagus
×
High-Intensity Interval Training
×
Clear all
NCT07375420
2026-02-02
OPTIMUS
University of Surrey
Phase NA
Recruiting
50 enrolled